Navigation Links
A rare association: Non-islet cell tumor hypoglycemia
Date:6/17/2008

Non-islet cell tumor hypoglycemia (NICTH) is a rare association between spontaneous hypoglycemia and tumors derived from tissues other than the pancreatic islets. It was initially associated with abdominal soft tissue sarcomas, although other tumor types have been described.

The pathogenesis of hypoglycemia in NICTH may involve a variety of mechanisms, including excessive consumption of glucose by what is typically a large tumor; inadequate production of counterregulatory hormones, such as growth hormone or cortisol; or ectopic or abnormal secretion of insulin or insulin-like growth factor-2 (IGF-II) and IGF-binding proteins. This last mechanism seems to be the most frequent and best characterized in patients with typical NICTH. Insulin secretion by the non-beta-cell tumor is, however, extremely rare and most cases published are secondary to secretion of an incompletely processed IGF-II by the tumor (big IGF-II), which acts as an insulin-like factor in the insulin receptors, causing hypoglycemia

A research team led by Dr. Robert Diaz and his team from Spain have written an article to be published on March 28, 2008 in the World Journal of Gastroenterology. A 74-year-old patient with advanced sigmoid cancer, who suffered recurrent bouts of fasting hypoglycemia presented to them. The diagnostic work-up finally revealed the ectopic production of insulin by the tumor. The possible simultaneous presence of a pancreatic insulin-secreting primary tumor (insulinoma) was ruled out by different laboratory and imaging tests.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Grocery Manufacturers Association: US Food & Drug Administration and European Food Safety Authority Affirm Safety of Certified Food Dyes
2. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
3. Texas Health Care Association: New Report on Long Term Care Workforce Spotlights Need to Boost Texas Medicaid Rates
4. AUDIO from Medialink and the National Lipid Association: Whats Your Triglycer-IQ?
5. A new weapon for attacking tumor invasion and metastasis
6. Ability to track stem cells in tumors could advance cancer treatments
7. Primary tumors can drive the growth of distant cancers
8. Primary Tumors Fuel Growth of Cancer Cells
9. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
10. Cancer-killing viruses influence tumor blood-vessel growth
11. Solid tumor cells not killed by radiation and chemotherapy become stronger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
Breaking Medicine Technology: